Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.
about
Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cellsNeuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke modelsResearch progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanismsMetabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficaciesCellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticlesPro-apoptotic versus anti-apoptotic properties of dietary resveratrol on tumoral and normal cardiac cells.Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro.Metabolism of skin-absorbed resveratrol into its glucuronized form in mouse skin.Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells.Herbal medicine and hepatocellular carcinoma: applications and challengesResveratrol: French paradox revisited.Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors.Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility.Herb-drug interactions: challenges and opportunities for improved predictions.Transport, stability, and biological activity of resveratrol.Role of membrane dynamics processes and exogenous molecules in cellular resveratrol uptake: consequences in bioavailability and activities.New trends for the medical treatment of endometriosis.Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation.Mechanisms and therapeutic prospects of polyphenols as modulators of the aryl hydrocarbon receptor.Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts.A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo.Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.Ethanol extract of Terminalia chebula fruit protects against UVB-induced skin damage.Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts.Resveratrol and inflammatory bowel disease: the evidence so far.Therapeutic Versatility of Resveratrol Derivatives.Absorption and Metabolism of Phenolics from Digests of Polyphenol-Rich Potato Extracts Using the Caco-2/HepG2 Co-Culture System.Differentiated Caco-2 cell monolayers exhibit adaptation in the transport and metabolism of flavan-3-ols with chronic exposure to both isolated flavan-3-ols and enriched extracts.N-Monosubstituted Methoxy-oligo(ethylene glycol) Carbamate Ester Prodrugs of Resveratrol
P2860
Q24626209-64E814BB-E932-436A-9D7D-C9FBA0C756FBQ26824390-8158581B-E3EA-49CE-A074-222A8216FC19Q28067369-72857695-FEFF-4B6A-8833-252688AF4D68Q28477935-1A4128E8-B8BC-4B36-B11D-1BEEACF1E6E5Q28538811-72D277B2-3BB6-40D8-9248-182603FB50EFQ33889566-AB9A9EF7-9AAD-4EE7-9117-B14F0C124C70Q34559483-7E06A787-6256-466D-A150-AF43074EE593Q34704230-0E46739A-8734-4D10-A4B5-E8BBA34C9505Q35013544-BAFA850D-8516-429D-9DA3-E10C0B38AED0Q35117008-3BE33CC6-F596-4118-9007-4C4E1C3810A2Q36099455-12CDD8D4-26A7-499B-992D-A32C91DD717DQ36717019-38838882-3F0E-43C7-AE30-C5E58BECB2F9Q37496597-9DB7F203-B29E-4E6F-92E9-0014EA5A2165Q37512665-09106FC6-51E9-49F2-BD0E-3DA7F6CCE711Q37603890-F0361938-8102-4B88-9C12-49258C8C9DB3Q37831931-0EC8E330-FAED-4345-B3FD-97AE9DC0E441Q37885882-A66B0941-7D07-4037-80FC-C668A5AF8CBEQ38008481-5F63D0B2-3C1C-4551-9AC9-A1A61A8AE736Q38550350-F3C5A2BE-7589-43DB-8F01-679F8EBD238EQ39176010-0BFE6C97-E085-4091-AA00-68CBD2BF6E9FQ39180818-E2DB43D0-602C-4017-B9B9-C607B442E4D1Q39239252-07A00E81-90C8-4CAE-8A74-B1E0D5520512Q39343138-4570AE1D-6EA5-4938-84A8-1EA218EDC1A1Q39383463-BAF44DB0-5557-4881-92AA-FB7745C8F066Q39738133-086EBB8C-9700-4A5F-9B35-1D358086DA15Q40528109-A742ACCC-F51B-4F21-A6A8-C16E06A2B0EEQ46250847-FA7A2E90-A88B-421D-9F6F-E32D09151486Q47126437-7DAD9D95-AF6E-43BE-8AFE-6CD27916B9DBQ48253280-5FDFA8D5-B354-4F1B-8047-0C5D983631F4Q50216018-642C2299-675D-481D-B5D8-5D25501136EEQ57974082-49C80EA0-789A-45D8-894C-34A56B2E7421
P2860
Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Resveratrol in human hepatoma ...... bility of detoxifying enzymes.
@ast
Resveratrol in human hepatoma ...... bility of detoxifying enzymes.
@en
type
label
Resveratrol in human hepatoma ...... bility of detoxifying enzymes.
@ast
Resveratrol in human hepatoma ...... bility of detoxifying enzymes.
@en
prefLabel
Resveratrol in human hepatoma ...... bility of detoxifying enzymes.
@ast
Resveratrol in human hepatoma ...... bility of detoxifying enzymes.
@en
P2093
P356
P1476
Resveratrol in human hepatoma ...... ibility of detoxifying enzymes
@en
P2093
Allan Lançon
Brigitte Jannin
Dominique Delmas
Gérard Lizard
Marie-Christine Chagnon
Nathalie Hanet
Norbert Latruffe
Yves Artur
P304
P356
10.1124/DMD.106.013664
P577
2007-02-07T00:00:00Z